Skip to Content

Guggenheim SMid Cap Value A SEVAX Fund Analysis

| Medalist Rating as of | See Guggenheim Investment Hub

Morningstar’s Analysis SEVAX

Will SEVAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The managers' experience is a key strength.

Analyst Andrew Redden

Andrew Redden

Analyst

Summary

Guggenheim SMid Cap Value's seasoned team but conventional hybrid approach make the strategy a decent but not stellar offering.

Rated on Published on

Unlock our full analysis with Morningstar Investor